SCHEMBL9150273

SCHEMBL9150273

COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OCCOC)C1c1cccc(C(=O)OC)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 3/20 0.64
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
CYP1A2 P05177 4/20 0.60
CYP3A4 P08684 4/20 0.60
CYP2C9 P11712 4/20 0.60
CYP2C19 P33261 4/20 0.60
LMNA P02545 3/20 0.60
MAPT P10636 3/20 0.60
CYP2D6 P10635 2/20 0.60
TSHR P16473 2/20 0.60
NFKB1 P19838 2/20 0.60
THPO P40225 2/20 0.60
ADORA3 P0DMS8 2/20 0.58
CACNA1C Q13936 4/20 0.57
CACNA1F O60840 3/20 0.57
CACNA1D Q01668 3/20 0.57
CACNA1S Q13698 3/20 0.57
HIF1A Q16665 3/20 0.56
POLB P06746 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9157114 0.93 MEN1 (0.70) CACNA1BMEN1KMT2ACYP1A2CYP3A4
SCHEMBL19017149 0.87 ADORA3 (0.60) MEN1KMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL8949344 0.86 CACNA1B (0.52) CACNA1BMEN1KMT2ACYP1A2CYP3A4
SCHEMBL9149860 0.86 MEN1 (0.69) CACNA1BMEN1KMT2ACYP1A2CYP3A4
SCHEMBL3024959 0.84 CACNA1B (0.62) CACNA1BMEN1KMT2ACYP1A2CYP3A4
SCHEMBL9150297 0.83 CACNA1B (0.71) CACNA1BMEN1KMT2ACYP1A2CYP3A4
SCHEMBL10830852 0.83 ADORA3 (0.72) CACNA1BMEN1KMT2ACYP1A2CYP3A4
SCHEMBL9476417 0.82 MEN1 (0.84) CACNA1BMEN1KMT2ACYP1A2CYP3A4
SCHEMBL18996989 0.81 MEN1 (0.58) CACNA1BMEN1KMT2ACYP1A2CYP3A4
SCHEMBL19002115 0.81 CACNA1C (0.58) CACNA1BMEN1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5403849-A Treatment of central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1995-04-04 US disclosed